HH Biotechnology Holdings Co. through its various subsidiaries, is engaged in the commercial and residential real estate leasing, management, consulting, investment, development and sales in the city of Shenyang, Liaoning Province, in the People' Republic of China. The company is headquartered in Shenyang, Liaoning. The company went IPO on 2012-07-23. The firm's business segments are Property for sale, and Rental income and Income of management fee of commercial buildings. The firm conducts all operations through its direct and indirect subsidiaries, which include Shenyang Maryland International Industry Company Limited and Silverstrand International Holdings Company Limited. The company is focused primarily on real estate leasing, management and consulting activities in the city of Shenyang.